Skip to main content

FRX · Fennec Pharmaceuticals Inc. · Documents

13.2900 CAD -1.1700 (-8.09%) At close · Nov 5 Intraday price with Plus

The company's reports, filings, earnings calls and investor events, most recent first. Search these from Claude or ChatGPT →

Annual report Ended Dec 31, 2025 Revenue $44.64M down 6.1% 10-K filed Mar 27, 2026 Quarterly report FY2026 Q2 Revenue $17.87M up 85.2% 10-Q filed Aug 13, 2026 Latest results Financial results 8-K filed Mar 24, 2026 Earnings call Q2 2026 earnings call Held Aug 11, 2026
2026
Sep 17
Current report 8-K
Other events AI summary on its way
Aug 13
Quarterly report 10-Q FY2026 Q2, ended Jun 30
Quarterly report for FY2026 Q2 AI summary on its way
Revenue $17.87M ▲ 85.2% Net income $1.97M Diluted EPS $0.05
Aug 13
Report SEDAR+
MD&A
May 22
Current report 8-K Events of May 21
Other events AI summary on its way
May 14
Quarterly report 10-Q FY2026 Q1, ended Mar 31
Quarterly report for FY2026 Q1 AI summary on its way
Revenue $15.11M ▲ 72.6% Net income $201K Diluted EPS $0.01
May 14
Report SEDAR+
MD&A
Apr 28
Proxy statement DEF 14A Meeting Jun 10, 2026
Proxy statement AI summary on its way
Apr 22
Current report 8-K
Other events AI summary on its way
Apr 7
Current report 8-K
Other events AI summary on its way
Mar 27
Report SEDAR+
MD&A
Showing 1–50 of 527 documents